Biotech is all about big bets.
Make the odds in your favor.

Negotiating a fundraise? Committing to a GP? Selecting a lead indication? We provide rigorous financial analysis to make sure the odds are in your favor.

Our Services

🎯
For Founders

Don't leave millions on the table

High-stakes negotiation support

Forensic valuation analysis for high-stakes negotiations. We identify weaknesses in your counterparty's model so you can defend your valuation with confidence.

Learn more Click to learn more
📈
For LPs

Pick the biotech investors who are winning

Identify which funds win across market cycles

Proprietary returns modeling platform identifies which funds and strategies win in changing market regimes—and whether they are lucky or good.

Learn more Click to learn more
🔍
For Teams

Analytical firepower for your key decisions

Battle-tested models and frameworks

Battle-tested DCF models, market models and indication selection frameworks. Whether you need to convince your board, challenge a team's assumptions, or validate your thesis, we provide the analytical firepower.

Coming soon Coming soon
For Investors

Be the fund that wins the AI era

Own your competitive advantage

Don't buy AI tools. Own them. We build custom automation to support you and your portfolio companies: helping you build your AI moat.

Learn more Click to learn more

Trusted by industry leaders

Our research and data is trusted by top university endowments, large family offices, leading private and public investors, and biotech founders from pre-seed to public markets.

$100M+
Value added for clients
Our analysis has directly driven valuation increases for our clients by over $100M

Research and Education

We also conduct research on biotech financial markets, and provide educational materials to help biotech professionals understand markets.

How to get biotech back on track

Why does biotech languish when tech soars? Why do good drugs go unfunded while hype gets billions?

We're researching a controversial thesis: financial markets reward speculation over innovation. And it's holding back medicine.

Free content and tools

Educational resources for biotech finance professionals, including blog posts, courses, and videos from our archive.